-
Something wrong with this record ?
The role of iron in the pathogenesis of atherosclerosis
P. Kraml
Language English Country Czech Republic
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Atherosclerosis blood diagnosis epidemiology MeSH
- Hemochromatosis blood diagnosis epidemiology MeSH
- Cardiovascular Diseases blood diagnosis epidemiology MeSH
- Humans MeSH
- Macrophages metabolism pathology MeSH
- Oxidative Stress physiology MeSH
- Iron blood MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Ferritin and increased iron stores first appeared on the list of cardiovascular risk factors more than 30 years ago and their causal role in the pathogenesis of atherosclerosis has been heavily discussed since the early 1990s. It seems that besides traditional factors such as hyperlipoproteinemia, hypertension, diabetes mellitus, obesity, physical inactivity, smoking and family history, high iron stores represent an additional parameter that could modify individual cardiovascular risk. The role of iron in the pathogenesis of atherosclerosis was originally primarily associated with its ability to catalyze the formation of highly reactive free oxygen radicals and the oxidation of atherogenic lipoproteins. Later, it became clear that the mechanism is more complex. Atherosclerosis is a chronic fibroproliferative inflammatory process and iron, through increased oxidation stress as well as directly, can control both native and adaptive immune responses. Within the arterial wall, iron affects all of the cell types that participate in the atherosclerotic process (monocytes/macrophages, endothelial cells, vascular smooth muscle cells and platelets). Most intracellular iron is bound in ferritin, whereas redox-active iron forms labile iron pool. Pro-inflammatory and anti-inflammatory macrophages within arterial plaque differ with regard to the amount of intracellular iron and most probably with regard to their labile iron pool. Yet, the relation between plasma ferritin and intracellular labile iron pool has not been fully clarified. Data from population studies document that the consumption of meat and lack of physical activity contribute to increased iron stores. Patients with hereditary hemochromatosis, despite extreme iron storage, do not show increased manifestation of atherosclerosis probably due to the low expression of hepcidin in macrophages.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19030532
- 003
- CZ-PrNML
- 005
- 20200309144214.0
- 007
- ta
- 008
- 190830s2017 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933589 $2 doi
- 035 __
- $a (PubMed)28379030
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kraml, Pavel, $d 1960- $7 jn20000401469 $u Second Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
- 245 14
- $a The role of iron in the pathogenesis of atherosclerosis / $c P. Kraml
- 520 9_
- $a Ferritin and increased iron stores first appeared on the list of cardiovascular risk factors more than 30 years ago and their causal role in the pathogenesis of atherosclerosis has been heavily discussed since the early 1990s. It seems that besides traditional factors such as hyperlipoproteinemia, hypertension, diabetes mellitus, obesity, physical inactivity, smoking and family history, high iron stores represent an additional parameter that could modify individual cardiovascular risk. The role of iron in the pathogenesis of atherosclerosis was originally primarily associated with its ability to catalyze the formation of highly reactive free oxygen radicals and the oxidation of atherogenic lipoproteins. Later, it became clear that the mechanism is more complex. Atherosclerosis is a chronic fibroproliferative inflammatory process and iron, through increased oxidation stress as well as directly, can control both native and adaptive immune responses. Within the arterial wall, iron affects all of the cell types that participate in the atherosclerotic process (monocytes/macrophages, endothelial cells, vascular smooth muscle cells and platelets). Most intracellular iron is bound in ferritin, whereas redox-active iron forms labile iron pool. Pro-inflammatory and anti-inflammatory macrophages within arterial plaque differ with regard to the amount of intracellular iron and most probably with regard to their labile iron pool. Yet, the relation between plasma ferritin and intracellular labile iron pool has not been fully clarified. Data from population studies document that the consumption of meat and lack of physical activity contribute to increased iron stores. Patients with hereditary hemochromatosis, despite extreme iron storage, do not show increased manifestation of atherosclerosis probably due to the low expression of hepcidin in macrophages.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ateroskleróza $x krev $x diagnóza $x epidemiologie $7 D050197
- 650 _2
- $a kardiovaskulární nemoci $x krev $x diagnóza $x epidemiologie $7 D002318
- 650 _2
- $a hemochromatóza $x krev $x diagnóza $x epidemiologie $7 D006432
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x krev $7 D007501
- 650 _2
- $a makrofágy $x metabolismus $x patologie $7 D008264
- 650 _2
- $a oxidační stres $x fyziologie $7 D018384
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, Supplementum 1 (2017), s. S55-S67
- 773 0_
- $t Supplement on the occasion of the 85th European Atherosclerosis Society meeting : $g (2017), s. S55-S67 $w MED00200900
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28379030 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20190830 $b ABA008
- 991 __
- $a 20200309144632 $b ABA008
- 999 __
- $a ok $b bmc $g 1440168 $s 1069020
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 66 $c Supplementum 1 $d S55-S67 $e 2017Apr05 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2017 $d S55-S67 $m Supplement on the occasion of the 85th European Atherosclerosis Society meeting $x MED00200900
- LZP __
- $b NLK118 $a Pubmed-20190830